Published in the Journal of Neuroscience, a discovery by Marco Martina, MD, PhD, associate professor in Physiology, sheds new light on the selective vulnerability of cell types in preclinical models of ataxia.
P. Hande Ozdinler, PhD, has been awarded three grants totaling more than $2.5 million. The funds will be used to increase her research efforts into the mechanisms behind amyotrophic lateral sclerosis.
While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.
More suspected stroke victims received emergency care and potentially life-saving treatments in Chicago’s stroke centers thanks to a 2011 policy change under the Illinois Primary Stroke Center Act.
A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.
In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be able to search for effective treatments.
Alzheimer’s drug may act like bad electrician, messing up wiring in brain and nervous system.
New Role for Ancient Clock The pancreas has its own molecular clock. Now, for the…